These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23820828)

  • 81. Mechanisms of exposure therapy: how neuroscience can improve psychological treatments for anxiety disorders.
    McNally RJ
    Clin Psychol Rev; 2007 Jul; 27(6):750-9. PubMed ID: 17292521
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Enhancing exposure-based therapy from a translational research perspective.
    Hofmann SG
    Behav Res Ther; 2007 Sep; 45(9):1987-2001. PubMed ID: 17659253
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Treatment of pediatric anxiety disorders.
    Rapp A; Dodds A; Walkup JT; Rynn M
    Ann N Y Acad Sci; 2013 Nov; 1304():52-61. PubMed ID: 24279893
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Potential of D-cycloserine in the treatment of behavioral and neuroinflammatory disorders in Parkinson's disease and studies that need to be performed before clinical trials.
    Pawlak CR; Chen FS; Wu FY; Ho YJ
    Kaohsiung J Med Sci; 2012 Aug; 28(8):407-17. PubMed ID: 22892161
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pharmacological treatments of cerebellar ataxia.
    Ogawa M
    Cerebellum; 2004; 3(2):107-11. PubMed ID: 15233578
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Social phobia: diagnostic issues and review of cognitive behavioral treatment strategies.
    Juster HR; Heimberg RG; Holt CS
    Prog Behav Modif; 1996; 30():74-98. PubMed ID: 7567677
    [No Abstract]   [Full Text] [Related]  

  • 87. Harnessing N-methyl-d-aspartate receptors for new treatment development in psychiatry: positive lessons from negative studies.
    Javitt DC
    Am J Psychiatry; 2013 Jul; 170(7):699-702. PubMed ID: 23820828
    [No Abstract]   [Full Text] [Related]  

  • 88. Effects of D-cycloserine on extinction: translation from preclinical to clinical work.
    Davis M; Ressler K; Rothbaum BO; Richardson R
    Biol Psychiatry; 2006 Aug; 60(4):369-75. PubMed ID: 16919524
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder.
    Rothbaum BO
    Am J Psychiatry; 2008 Mar; 165(3):293-6. PubMed ID: 18316423
    [No Abstract]   [Full Text] [Related]  

  • 90. Recent advances in the psychosocial treatment of social anxiety disorder.
    Hofmann SG
    Depress Anxiety; 2010 Dec; 27(12):1073-6. PubMed ID: 21132801
    [No Abstract]   [Full Text] [Related]  

  • 91. D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review.
    Schade S; Paulus W
    Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26364274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 5.